K

Keystone Clinical Studies, LLC | Norristown, PA

Research site

(Unclaimed)

Location

2460 General Armistead Avenue Suite 300, Norristown, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Rapastinel

Gabitril

Armodafinil

ATH-1017

Lecanemab

Bitopertin

Dasotraline

RO4917838

Serotonin

BHV-4157

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 25 total trials

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting

Early Alzheimer's Disease

Drug: Placebo

Drug: Lecanemab

AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

The primary purpose of this study is to determine whether treatment with lecanemab is superior to placebo on change from baseline of the Preclinical...

Enrolling

Preclinical Alzheimer's Disease

Early Preclinical Alzheimer's Disease

Drug: Lecanemab

Drug: Placebo

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease (LIFT-AD)

This study is designed to evaluate safety and efficacy of fosgonimeton (ATH-1017) in the treatment of mild to moderate Alzheimer's disease with a ran...

Active, not recruiting

Alzheimer Disease

Dementia of Alzheimer Type

Drug: Placebo

Drug: ATH-1017

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

The objective of this study is to determine the safety and tolerability of fosgonimeton (ATH-1017) in subjects with mild to moderate Alzheimer's dise...

Active, not recruiting

Alzheimer Disease

Drug: ATH-1017